Latest retinopathy of prematurity Stories
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants, researchers found that targeting saturations of 85 percent to 89 percent compared with 91 percent to 95 percent had no significant effect on the rate of death or disability at 18 months, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting....
redOrbit Staff & Wire Reports - Your Universe Online The researchers behind a large study on the effects of oxygen levels on premature infants have been reprimanded by the US Department of Health and Human Services (HHS) for failing to inform the parents of those children of the risks involved with the study. In a letter dated March 7, Lisa R. Buchanan of the HHS Office for Human Research Protections (OHRP) wrote that a portion of the University of Alabama-Birmingham (UAB) study...
Deal Enhances Shire's Late-Stage Pipeline with the Acquisition of a Phase II Protein Replacement Therapy Being Investigated for the Prevention of Retinopathy of Prematurity LEXINGTON, Massachusetts, March 12, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), announces that it has acquired Premacure AB of Uppsala, Sweden, a privately held biotechnology company developing a protein replacement therapy, currently in Phase II development, for the prevention of retinopathy...
New research in Nature concludes the eye – which depends on light to see – also needs light to develop normally during pregnancy. Scientists say the unexpected finding offers a new basic understanding of fetal eye development and ocular diseases caused by vascular disorders – in particular one called retinopathy of prematurity that can blind premature infants. The research, led by scientists at Cincinnati Children's Hospital Medical Center and the University of California, San...
CINCINNATI, Jan. 16 2013 /PRNewswire-USNewswire/ -- New research in Nature concludes the eye - which depends on light to see - also needs light to develop normally during pregnancy. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Scientists say the unexpected finding offers a new basic understanding of fetal eye development and ocular diseases caused by vascular disorders - in particular one called retinopathy of prematurity that can blind premature infants. The...
Retinopathy of prematurity (ROP) is the second most common cause of childhood blindness in the United States, occurring in half of premature infants born earlier than or at 28 weeks gestational age. The condition is caused by abnormal blood vessel development in the retina of the eye. ROP risk increases with decreasing gestational age. A study by researchers at Brigham and Women's Hospital (BWH) suggests that the antioxidant, rhSOD (recombinant human Cu/Zn superoxide dismutase), reduces...
Image Credit: Photos.com --- Connie K. Ho for RedOrbit.com Mark your calendars: May is Healthy Vision Month. Since 2003, the National Eye Institute (NEI) has promoted May with this national eye health observance. During Health Vision Month, NEI hopes to increase awareness about early diagnosis and treatment of vision loss. The NEI, under the National Institute of Health (NIH), helps develop the federal government’s research on the visual system and eye diseases. The NIH is the...
DALLAS, July 28, 2011 /PRNewswire-USNewswire/ -- Children's Eye Foundation and RIPROP join forces to support the development of a compact and inexpensive device to detect retinopathy of prematurity (ROP), a treatable disorder that can cause blindness in premature babies. This collaboration was motivated by Dan Lochmann, the father of a girl left blind in one eye from ROP. Lochmann founded RIPROP in hopes of one day saying "RIP" to ROP and to fund research into both preventative measures...
A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity.The results of a multicenter clinical trial led by researchers at The University of Texas Health Science Center at Houston (UTHealth) are published in the Feb. 17 issue of The New England Journal of Medicine.Retinopathy of prematurity is a leading cause of childhood blindness worldwide. In the...
The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina, Medical College of Georgia researchers say.Ischemic retinopathy is characterized by uncontrolled formation of new blood vessels in the retina, and is seen in diseases such as diabetic retinopathy and retinopathy of prematurity. While this blood vessel formation, called neovascularization, can benefit ischemic heart disease and wound healing, it is bad in the...
